Bile duct cells in primary biliary cirrhosis are 'primed' for apotosis

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 7, 1998, Pages 553-557

  Graham, Alexandra M ^a,b   Dollinger, Matthias M ^a   Howie, Sarah E M ^a   Harrison, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Bax; Bcl 2; Fas; Primary biliary cirrhosis

Indexed keywords

CELL PROTEIN; FAS ANTIGEN; KI 67 ANTIGEN; METHOTREXATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; BILE DUCT; CELL CYCLE; CELL PROLIFERATION; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LYMPHOMA; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031820371     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199807000-00005     Document Type: Article

References (50)

1. O'Donohue J, Williams R. Primary biliary cirrhosis. Q J Med 1996; 89:5-13.
2. Schulte-Herman R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver. Prog Liver Diseases 1995; 13:1-35.
3. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21:1725-1741.
4. Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993; 86:393-399.
5. Stemerowicz R, Hopf U, Moller B, Wittenbrink C, Rodloff A, Reinhardt R. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R (rough)-mutants of Enterobacteriaceae? Lancet 1988; ii:1166-1170.
6. Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M. Relation between Escherichia coli R (rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; ii:1419-1422.
7. Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JMT, Brumfitt W, Sherlock S. Bacteriuria in primary biliary cirrhosis. Gut 1994; 25:133-137.
8. Vilagut L, Vila J, Viñas O, Parés A, Ginès A, Jiménez de Anta MT, Rodés J. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 1994; 21:673-677.
9. Coppel RL, Gershwin ME. Primary biliary cirrhosis: the molecule and the mimic. Immunol Rev 1995; 144:17-49.
10. Si L, Whiteside TL, Schade RR, Starz TE, Van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol 1984; 4:262-272.
11. Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990, 12:306-313.
12. Björkland A, Festin R, Mendel-Hartvig I, Nyberg A, Lööf L, Tötterman TH. Blood and liver infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991; 13:1106-1111.
13. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993; 68:1049-1055.
14. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994; 1:357-364.
15. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induction in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994; 153:1778-1788.
16. Morita M, Watanabe Y, Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 1995; 21:1585-1593.
17. 1. Cancer Res 1992; 52:385-388.
18. 1. Proc Natl Acad Sci USA 1992; 89:5408-5412.
19. Fukuda K, Kojiro M, Chiu J-F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology 1993; 18:945-953.
20. Tovey MG, Gugenheim J, Guymarho J, Blanchard B, Vanden Broeke C, Gresser I. Genes for interleukin-1, interleukin-6, and tumor necrosis factor are expressed at markedly reduced levels in the livers of patients with severe liver disease. Autoimmunity 1991; 10:297-310.
21. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21:113-119.
22. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis and chronic hepatitis B. Clin Exp Immunol 1996; 105:254-259.
23. Tsuneyama K, Van de Water J, Leung PSC, Cha S, Nakanuma Y, Kaplan M. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and B1/B7 expression. Hepatology 1995; 21:1031-1037.
24. Spengler U, Leifield L, Braunschweiger I, Dumoulin FL, Lechmann M, Sauerbruch T. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 1997; 26:31-36.
25. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9:1799-1805.
26. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC. Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene 1994; 9:1791-1798.
27. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol and Cell Biol 1995; 15:3032-3040.
28. Wyllie AH. Death gets a brake. Nature 1994; 369:272-273.
29. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138:867-873.
30. Scheuer PJ. Liver Biopsy Interpretation. 4th Edn. London: W.B. Saunders; 1988.
31. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24:1-7.
32. Nakanuma Y, Ohta G, Kono N, Koayashi K, Kato Y. Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis. Liver 1983; 3:238-248.
33. Nakanuma Y, Harada K. Florid duct lesion in primary biliary cirrhosis shows highly proliferate activities. J Hepatol 1993; 19:216-221.
34. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994; 144:460-465.
35. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996; 429:119-129.
36. Koukoulis GK, Shen J, Iyer A, Foster P, Ganger D, Williams J. Immunolocalization of bcl-2 and MET oncoproteins in biliary ductules and ducts of normal liver, cirrhosis and ductopenic rejection. AASLD Meeting, Chicago 1995; Abstract.
37. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in-vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Path 1994; 145:1323-1336.
38. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19:1354-1359
39. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182:1223-1230.
40. Okazaki M, Hino K, Fujii K, Hanada H, Nakakishi Y, Kanazawa S. Immunohistochemical study of Fas antigen in liver of patients with chronic hepatitis and autoimmune liver disease. Int Hepatol Comm 1995; 3:285-289.
41. Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumour necrosis factor and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85:3183-3190.
42. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 1995; 9:1227-1232.
43. Bernuau D, Feldmann G, Degott C, Gisselbrecht C. Ultrastructural lesions of bile ducts in primary biliary cirrhosis Hum Path 1981; 12:782-793.
44. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation in biliary epithelial cells and in hepatocytes in primary biliary cirrhosis. AASLD Meeting, Chicago 1995; Abstract.
45. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W. Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 1989; 245:301-305.
46. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J Exp Med 1989; 169:1747-1756.
47. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364:806-809.
48. Oltvai ZN, Milliman CL, Korsmeyer SJ. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74:609-619.
49. Hung WC, Chiuang LY. Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is asssociated with enhanced expression of bax gene product. Biochem Biophys Res Commun 1996; 229:11-15.
50. Boise LH, González-Garcia M. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597-608.